Use Of Ketogenic Compounds For Treatment Of Age-associated Memory Impairment

  • Published: Aug 29, 2018
  • Earliest Priority: Apr 03 2006
  • Family: 32
  • Cited Works: 5
  • Cited by: 0
  • Cites: 0
  • Additional Info: Cited Works Full text
Abstract

This invention relates to the field of therapeutic agents for the treatment of Age-Associated Memory Impairment (AAMI). In particular, the present invention utilizes compositions comprising at least one compound capable of elevating ketone body concentrations in a mammal (e.g., ketogenic compounds), administered in an amount effective for treatment or prevention of loss of cognitive function caused by reduced neuronal metabolism in AAMI. In one embodiment, the composition includes medium chain triglycerides (MCT). In another embodiment, the compositions are administered in the presence of carbohydrate. The present invention also relates to oral dosage forms, in particular, a nutritional drink comprising at least one compound capable of elevating ketone body concentrations in a mammal.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 29, 2018
  • Application: Apr 3, 2007
    EP EP 07797196 A
  • Priority: Apr 3, 2007
    US US 2007/0065873 W
  • Priority: Apr 3, 2006
    US US 74414006 P

Download Citation


Sign in to the Lens

Feedback